Compare VFS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFS | PCVX |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Vietnam | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 6.0B |
| IPO Year | N/A | 2020 |
| Metric | VFS | PCVX |
|---|---|---|
| Price | $3.39 | $46.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $5.83 | ★ $101.67 |
| AVG Volume (30 Days) | 532.4K | ★ 1.5M |
| Earning Date | 11-21-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,554,394,588.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $43.19 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 81.20 | N/A |
| 52 Week Low | $2.56 | $27.66 |
| 52 Week High | $4.65 | $93.77 |
| Indicator | VFS | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 55.49 | 54.15 |
| Support Level | $3.34 | $42.40 |
| Resistance Level | $3.67 | $45.15 |
| Average True Range (ATR) | 0.11 | 1.95 |
| MACD | 0.01 | -0.30 |
| Stochastic Oscillator | 47.64 | 68.65 |
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.